Mangalam Drugs & Organics Limited (MANGALAM.NS) NSE

Currency In INR

AD

Valuation

Market Cap429.76M
Enterprise Value1.48B
P/E Ratio-1.51
PEG Ratio0.01
Price/Sales Ratio0.25
Price/Book Ratio0.56
Enterprise/Revenue0.25
Enterprise/EBITDA-6.59

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.16
Operating Margin-0.12
AD

Management Effectiveness

Return On Assets0
Return On Equity-0.33

Income Statement

Revenue2.32B
Revenue/Share146.67
Gross Profit232.46M
EBITDA-149.03M
Net Income-444M
Diluted EPS-28.05

Balance Sheet

Total Cash7.51M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share65.11

Price History

52-Week Change-51.55
52-Week High77.6
52-Week Low22.8
Moving Average 50 Days28.46
Moving Average 200 Days30.32

Statistics

Average Volume39,885
Shares Outstanding15.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD